ARNA Related Trader Talk
-
Arena Pharmaceuticals (ARNA) Weakens Mid-Day
-
Arena Pharmaceuticals (ARNA) Lifts Ahead of Tomorrow's BELVIQ Launch
-
This Week's BELVIQ Launch Has Arena (ARNA) in the Cross-hairs
-
Stocks Crossing 50-Day SMA 05/07: (PFE) (JPM) (ARNA) Above; (FTR) (GGB) (ORCL) Below
-
Arena (ARNA) Clears Final BELVIQ Marketing Hurdle; Could Make U.S. Debut in June
-
Arena Pharmaceuticals (ARNA) Withdraws EU BELVIQ Application
-
Stocks Crossing 50-Day SMA 03/25: (ZAZA) (LOW) (CTRP) Above; (APOL) (ARNA) (USG) Below
-
Arena (ARNA), VIVUS (VVUS) Face Uphill Obesity Battle as Costs Play Key Role
-
VIVUS (VVUS) Cuts Qsymia Price by About 70%; Arena (ARNA) on Watch
-
Arena (ARNA) Short Interest Still High into Q4 Results
-
Arena (ARNA) Will Need Lower Co-Payments, Broader Coverage for Belviq Success (VVUS)
-
VIVUS (VVUS) Peers Tick Higher Amid Positive Qsymia Data (ARNA) (OREX)
-
Shorts Target VIVUS (VVUS) Following January Pop; May be Entering 'Oversold' Territory
-
Stocks Crossing 50-Day SMA 01/22: (FCX) (CLSN) (T) Above; (ARNA) (VZ) (OZM) Below
-
Stocks Crossing 50-Day SMA 12/26: (INTC) (BIDU) (ACI) Above; (KORS) (COH) (ARNA) Below
-
Arena (ARNA), Orexigen (OREX) on Watch as Major PBM Adds Qsymia to Formularies List (VVUS)
-
Orexigen (OREX) Slumps as Many Expected 'Better News' for Contrave
-
Arena Pharmaceuticals' (ARNA) Lorcaserin Proposed for DEA Schedule IV
-
Stocks Crossing 50-Day SMA 12/10: (HPQ) (MCP) (ACI) Above; (AIG) (SIRI) (SWHC) Below
-
VIVUS (VVUS) Surges Higher on Aetna Bulletin (ARNA)
-
Stocks Crossing 50-Day SMA 11/19: (GMCR) (ARNA) (X) Above; (CSCO) (PCS) (UTSI) Below
-
Stocks Crossing 50-Day SMA 11/13: (DVAX) (ARNA) (DKS) Above; (CELG) (ALU) (PMT) Below
-
VIVUS (VVUS) Ticks Lower; Wider Q3 Loss Attributed to Qsymia Launch, Expansion (ARNA) (OREX)
-
Latest Qsymia Data Shapes Up Potential Bear Case for VIVUS (VVUS) and Peers (ARNA) (OREX)
-
Obesity Pill Pharma Gear Up to Report Q3 Results Next Week (ARNA) (OREX) (VVUS)
-
Stocks Crossing 50-Day SMA 10/24: (TEVA) (ARNA) (ILMN) Above; (GLW) (NFX) (IACI) Below
-
Arena (ARNA), Orexigen (OREX) on Watch after CHMP Denies VIVUS (VVUS) Qsiva in EU
-
Arena (ARNA) Runs Higher as VIVUS (VVUS) Seeks Broader Obesity Pill Distribution
-
FDA Might Allow for Faster Approval of Obesity Drugs (VVUS) (ARNA) (OREX)
-
Stocks Crossing 50-Day SMA 10/08: (PLCM) (ARNA) (MWW) Above; (FB) (SYMC) Below
-
VIVUS' (VVUS) Qsymia Prescription Insurer Pay Rate Rose 5% in Week Two
-
Stocks Crossing 50-Day SMA 09/24: (KWK) (NVE) (RSH) Above; (ARNA) (ATML) (ALU) Below
-
Stocks Crossing 50-Day SMA 09/18: (RIMM) (ARNA) (ENR) Above; (CLWR) (DECK) (X) Below
-
VIVUS (VVUS) Gets Jump on Arena (ARNA); Quietly Discloses Qsymia Availability in U.S.
-
Arena Pharmaceuticals (ARNA) Sees Upside
-
Arena Pharma (ARNA) Moves to Session Lows on Volume
-
Arena Pharma (ARNA) Moves Higher; Sees European Belviq Approval in H113, All Debt Prepaid
-
Stocks Crossing 50-Day SMA 09/05: (ODP) (SWY) (FNSR) Above; (FRAN) (ARNA) (BP) Below
-
VIVUS (VVUS), Arena (ARNA) Tick Higher on Positive Orexigen (OREX) News
-
Stocks Crossing 50-Day SMA 09/04: (F) (ARNA) (SFD) Above; (NVDA) (ARMH) (CAT) Below
-
Obesity Drug Makers Gears Up for Busy Sept. Conference Schedule (ARNA) (OREX) (VVUS)
-
Stocks Crossing 50-Day SMA 08/28: (LXK) (BIDU) (P) Above; (ARNA) (FSL) (JOY) Below
-
Stocks Crossing 50-Day SMA 08/27: (HMA) (INTU) (D) Above; (ARNA) AA) (LUV) Below
-
Arena (ARNA), Orexigen (OREX) Lift With VIVUS (VVUS)
-
Arena (ARNA) Higher as VIVUS (VVUS) Downgrade is Company-Specific, Not Industry Issue
-
VIVUS (VVUS) Peers Pressured as Analyst Takes Cautious Stance on Obesity Drug (ARNA) (OREX)
-
Arena Pharmaceuticals (ARNA) Jumps on Takeover Speculation
-
Arena Pharma (ARNA) Ticks Higher Following Two Large Block Trades
-
VIVUS (VVUS) Slumps to Multi-Month Low, Nears $20 Support Level
-
Arena (ARNA) Looks to Break Losing Streak Following Qsymia Approval (VVUS) (OREX)
Back to ARNA Stock Lookup
